V-Wave Ltd. announced that renowned heart failure cardiologist William T. Abraham, M.D., is joining V-Wave as chief medical officer. Abraham makes this move to V-Wave after more than 16 years as director of the Division of Cardiovascular Medicine at the Ohio State University.

Healthcare technology, specifically healthcare applications (apps) for smartphone devices, is a rapidly growing field with vastly different targets and purposes. With continuous improvements in both tablets and smartphones, the healthcare app market is one that investors and innovators should watch closely in 2019, said data and analytics company GlobalData.

Diagnostic and Interventional Cardiology (DAIC) was named a finalist in the Social Media Presence category for the 2019 Azbee Awards, at both the regional and national levels. Bestowed annually by the American Society of Business Publication Editors (ASBPE), the Azbee Awards recognize the best editorial, online content and design in business-to-business (B2B) media.

National and international ultrasound societies are urging the U.S. Food and Drug Administration to remove the “black box” from ultrasound contrast agent (UCA) labels.

Swiss-based M.A. MedAlliance SA has been granted Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for Selution, its sustained limus release (SLR) drug-eluting balloon (DEB) catheter, for the treatment of coronary disease.